Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center
Clinical trials sponsored by Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center, explained in plain language.
-
Could a common antidote help stroke patients?
Disease control CompletedThis study tested whether giving N-Acetylcysteine (NAC) intravenously soon after an acute ischemic stroke could improve outcomes. Only 4 adults with moderate to severe stroke were enrolled. Researchers measured stroke severity and disability at 30 and 90 days. The trial is comple…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Which antibiotic wins for skin infections? study pits doxycycline against TMP-SMX
Disease control CompletedThis study compared two common antibiotics, doxycycline and TMP-SMX, for treating uncomplicated skin infections like boils and cellulitis. 269 people aged 9 to 85 took one of the drugs for 7 days. Researchers checked if the infection cleared up early, at the end of treatment, and…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 22, 2026 12:01 UTC
-
Male birth control pill moves closer to reality
Disease control CompletedThis study tests a new male hormone pill, dimethandrolone undecanoate (DMAU), as a potential daily contraceptive for men. Researchers gave single and repeated doses to 100 healthy men aged 18-50 to check safety and how the drug works in the body. The goal is to develop a reliable…
Phase: PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Feeding less to prevent baby fat: a tiny trial
Prevention CompletedThis study tested whether carefully reducing the amount of pumped breast milk or formula given to babies of overweight mothers could prevent them from becoming overweight at 6 months old. Researchers enrolled 60 mothers and their infants, measuring weight changes. The approach is…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Prevention
Last updated Jun 23, 2026 11:54 UTC
-
Monthly or as-needed? new study tests best timing for bladder therapy
Symptom relief CompletedThis study looked at two ways to schedule follow-up nerve stimulation treatments for overactive bladder: once a month or only when symptoms return. 37 women who had already completed 12 weekly sessions took part. The goal was to see if an as-needed schedule works as well as month…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated May 29, 2026 14:19 UTC
-
At-Home bladder treatment could rival clinic visits
Symptom relief CompletedThis study looked at whether a home-based nerve stimulation treatment (TTNS) works as well as a clinic-based version (PTNS) for overactive bladder. About 70 patients from a county hospital tried one of the two treatments and reported their symptoms and satisfaction. The goal was …
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated May 26, 2026 12:11 UTC
-
Can a simple communication tool cut unnecessary ICU care?
Knowledge-focused CompletedThis study tested a new way for doctors and families to talk about ICU care for very sick patients with advanced illnesses. Instead of continuing treatments indefinitely, they used 'time-limited trials' — agreements to try treatments for a set period and then check if the patient…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 24, 2026 05:50 UTC
-
Losing sleep may mess with your hormones and raise diabetes risk
Knowledge-focused CompletedThis study looked at how not getting enough sleep changes two key hormones, cortisol and testosterone, and whether those changes lead to insulin resistance—a major cause of type 2 diabetes. Researchers also checked how sleep loss affects food cravings, mood, inflammation, and bon…
Phase: EARLY_PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:07 UTC